Substitutional treatment of opioid abusers in Denmark;Substitutionsbehandlingen af opioidmisbrugere i Danmark

Ugeskrift for Laeger

Volumn 165, Issue 38, 2003, Pages 3620-3623

  Ishøy, Torben ^b   Iversen, Connie ^a  

^a Frederiksb Kommunes Radgivningsctr   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; DIAMORPHINE; LEVACETYLMETHADOL; METHADONE; OPIATE; ACETYLMETHADOL; BENZODIAZEPINE DERIVATIVE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ADDICTION; ALCOHOL ABUSE; ARTICLE; DENMARK; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG MEGADOSE; HUMAN; MAJOR CLINICAL STUDY; METHADONE TREATMENT; OPIATE ADDICTION; SUBSTANCE ABUSE; TREATMENT OUTCOME; QUESTIONNAIRE;

BENZODIAZEPINES; BUPRENORPHINE; DENMARK; HUMANS; METHADONE; METHADYL ACETATE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; QUESTIONNAIRES;

EID: 0142228151     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lowinson JH, Marion IJ, Joseph H et al. Methadone maintenance. I: Lowinson JH, Ruiz P, Millman RB, eds. Substance abuse. A comprehensive textbook. 2d ed. Baltimore, MD: Williams and Wilkins, 1992:552.
2. Bertschy G. Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci 1995;245:114-24.
3. O'Connor PG, Oliveto AH, Shi JM et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users a versus methadone clinic. Am J Med 1998;105:100-5.
4. Lov nr. 435 af 14. juni 1995 om ændring af lov om sygehusvæsenet og lov om udøvelse af lægegerning.
5. Lov nr. 432 af 14. juni 1995 om aendring af lov om social bistand.
6. Mattick R, Hall W. Key issues in methadone maintenance treatment. New South Wales, Australia: New South Wales University Press, 1992:92-104.
7. Caplehorn JR, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Aust 1991;154:195-9.
8. Caplehorn JR, Drummer OH. Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Aust NZJ Public Health 2002;26: 358-62.
9. Bleich A, Gelkopf M, Weizman T et al. Benzodiazeoine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. Isr J Psychiatry Relat Sci 2002;39:104-12.
10. Hansen SS. Drug abusers in Danish mental hospitals. Addiction 1997;92: 429-35.
11. Miller NS, Klamen D, Hoffmann NG et al. Prevalence of depression and alcohol and other drug dependence in addiction treatment populations. J Psychoactive Drugs 1998;28:111-24.
12. Donhue B, Acierno R, Kogan E. Relationship of depression with measures of social functioning in adult drug abusers. Addict Behav 1996;21:211-6.
13. Stofmisbrugere i metadonbehandling i København efter den 1. januar 1996. København: Embedslægeinstitutionen for Københavns og Frederiksberg Kommuner, 2001.
14. Dáunno T, Pollack HA. Changes in methadone treatment practices: results from a national panel study, 1888-2000. JAMA 2002;288:850-6.
15. Donny EC, Walsh SL, Bigelow GE et al. High-dose metahdone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl) 2002;161: 202-12.